TWI365753B - Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases - Google Patents

Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases

Info

Publication number
TWI365753B
TWI365753B TW095115754A TW95115754A TWI365753B TW I365753 B TWI365753 B TW I365753B TW 095115754 A TW095115754 A TW 095115754A TW 95115754 A TW95115754 A TW 95115754A TW I365753 B TWI365753 B TW I365753B
Authority
TW
Taiwan
Prior art keywords
treatment
propenoic acid
dermatological diseases
adamantyl
methoxydiphenyl propenoic
Prior art date
Application number
TW095115754A
Other languages
English (en)
Chinese (zh)
Other versions
TW200716192A (en
Inventor
Claudio Pisano
Loredana Vesci
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of TW200716192A publication Critical patent/TW200716192A/zh
Application granted granted Critical
Publication of TWI365753B publication Critical patent/TWI365753B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
TW095115754A 2005-05-20 2006-05-03 Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases TWI365753B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.

Publications (2)

Publication Number Publication Date
TW200716192A TW200716192A (en) 2007-05-01
TWI365753B true TWI365753B (en) 2012-06-11

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095115754A TWI365753B (en) 2005-05-20 2006-05-03 Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases

Country Status (13)

Country Link
US (1) US7635719B2 (enExample)
EP (1) EP1890671B1 (enExample)
JP (1) JP5072833B2 (enExample)
KR (1) KR101307910B1 (enExample)
CN (1) CN101180028B (enExample)
AR (1) AR054361A1 (enExample)
AU (1) AU2006248981B2 (enExample)
BR (1) BRPI0611289A2 (enExample)
CA (1) CA2606567A1 (enExample)
IT (1) ITRM20050248A1 (enExample)
MX (1) MX2007014222A (enExample)
TW (1) TWI365753B (enExample)
WO (1) WO2006122883A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンC(Ascorbicacid)を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Also Published As

Publication number Publication date
AU2006248981A1 (en) 2006-11-23
WO2006122883A1 (en) 2006-11-23
TW200716192A (en) 2007-05-01
KR20080016573A (ko) 2008-02-21
US20080153916A1 (en) 2008-06-26
MX2007014222A (es) 2008-02-07
CN101180028A (zh) 2008-05-14
US7635719B2 (en) 2009-12-22
WO2006122883A9 (en) 2012-10-04
ITRM20050248A1 (it) 2006-11-21
HK1117737A1 (en) 2009-01-23
EP1890671A1 (en) 2008-02-27
KR101307910B1 (ko) 2013-09-16
CN101180028B (zh) 2010-12-08
AR054361A1 (es) 2007-06-20
JP2008540603A (ja) 2008-11-20
AU2006248981B2 (en) 2011-06-02
BRPI0611289A2 (pt) 2010-08-31
CA2606567A1 (en) 2006-11-23
JP5072833B2 (ja) 2012-11-14
EP1890671B1 (en) 2014-03-05

Similar Documents

Publication Publication Date Title
IL190338A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
SG10201912182UA (en) Improved modalities for the treatment of degenerative diseases of the retina
PT1976886E (pt) Meios e processos para o tratamento de doenças tumorais
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
PL1685834T3 (pl) Zastosowanie kwasu pinolenowego do leczenia otyłości
EP2091480A4 (en) SYSTEM FOR THE TREATMENT OF HEART TISSUE
GB0410399D0 (en) The treatment of respiratory disease
GB0410398D0 (en) The treatment of respiratory disease
IL186022A0 (en) Dermatological compositions and salts for the treatment of dermatological diseases
PT1881824E (pt) Utilização de triglicéridos docosaexaenóicos para o tratamento de doenças tumorais
GB0611240D0 (en) The treatment of increased sebum production
GB0523961D0 (en) The treatment of ophthalmic diseases
TWI365753B (en) Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
GB0611241D0 (en) The treatment of increased sebum production
PL2120953T3 (pl) Preparaty do miejscowego leczenia chorób skóry
EP1846013A4 (en) TREATMENT OF SKIN DISEASES
ZA200708279B (en) Dermatological compositions and salts for the treatment of dermatological diseases
GB0523964D0 (en) The treatment of ophthalmic diseases
ZA200606780B (en) Compounds for the treatment of diseases
ZA200802948B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
IL186916A0 (en) Use of insp052 polypeptide for the preparation of a medicament for treating diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees